Devroe Eric 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2025-11-14$2.24/sh−613$1,373→ 65,308 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.